Name
VAP-II
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for VAP-II
Name
Alternate Names
Actinomycin
Actinomycin AIV
Actinomycin C1
Actinomycin D
Actinomycin I1
Actinomycin IV
Actinomycindioic D-acid dilactone
Cosmegen
Dactino-mycin D
Meractinomycin
Oncostatin K
Abbreviations
ACD
ACT
ACT-D
ACTD
Acto-D
AD
Dact
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
003053
3053
Primary Site
Histology
None
Remarks
FDA approved use on Ewing's sarcoma, rhabdomyosarcoma, gestational trophoblastic neoplasms, testicular carcinoma, Wilm's tumor (antitumor antibiotic)
Coding
This drug should be coded
Name
Alternate Names
Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum
Abbreviations
CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP
Category
Chemotherapy
Subcategory
Alkylating agent
Platinum analog
NSC Number
119875
Primary Site
Histology
None
Remarks
An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.
Coding
This drug should be coded
Name
Alternate Names
29060-LE
Alkaban
LE-29060
Velban
Velbe
Velsar
Vinblastine
Vinblastine sulfate
Abbreviations
VBL
VELB
VLB
Category
Chemotherapy
Subcategory
Plant alkaloid
NSC Number
049842
49842
Primary Site
None
Histology
None
Remarks
A cell cycle specific chemotherapeutic agent; vinca plant alkaloid; mitotic inhibitor. FDA approved uses in 3rd line breast cancer, choriocarcinoma, palliative in stages III and IV Hodgkin's lymphoma, Kaposi's sarcoma, mycosis fungoides, palliative in non-Hodgkin's histiocytic/lymphocytic lymphoma, and advanced testicular carcinoma.
Coding
This drug should be coded